Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 397


Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Cámara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C.

J Antimicrob Chemother. 2012 Aug;67(8):1858-60. doi: 10.1093/jac/dks162. Epub 2012 May 7.


Tracing subsequent dissemination of a cluster of gonococcal infections caused by an ST1407-related clone harbouring mosaic penA alleles in Taiwan.

Chen CC, Yen MY, Wong WW, Li LH, Huang YL, Chen KW, Li SY.

J Antimicrob Chemother. 2013 Jul;68(7):1567-71. doi: 10.1093/jac/dkt059. Epub 2013 Mar 18.


Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Lewis DA, Sriruttan C, Müller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M.

J Antimicrob Chemother. 2013 Jun;68(6):1267-70. doi: 10.1093/jac/dkt034. Epub 2013 Feb 14.


Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.

Thakur SD, Starnino S, Horsman GB, Levett PN, Dillon JR.

J Antimicrob Chemother. 2014 Jun;69(6):1510-6. doi: 10.1093/jac/dkt543. Epub 2014 Feb 13.


Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.

Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, Hauser C, Furrer H.

BMC Infect Dis. 2014 Feb 25;14:106. doi: 10.1186/1471-2334-14-106.


Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.

Gose S, Nguyen D, Lowenberg D, Samuel M, Bauer H, Pandori M.

BMC Infect Dis. 2013 Dec 4;13:570. doi: 10.1186/1471-2334-13-570.


Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.

Lee H, Unemo M, Kim HJ, Seo Y, Lee K, Chong Y.

J Antimicrob Chemother. 2015 Sep;70(9):2536-42. doi: 10.1093/jac/dkv146. Epub 2015 Jun 17.


Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.

Carannante A, Prignano G, Cusini M, Matteelli A, Dal Conte I, Ghisetti V, D'Antuono A, Cavrini F, Antonetti R, Stefanelli P.

Clin Microbiol Infect. 2012 Jun;18(6):558-64. doi: 10.1111/j.1469-0691.2011.03619.x. Epub 2011 Oct 3.


Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.

Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, Saika T, Kobayashi I.

Int J Antimicrob Agents. 2006 Jan;27(1):20-6. Epub 2005 Nov 28.


Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.

Serra-Pladevall J, Barberá MJ, Rodriguez S, Bartolomé-Comas R, Roig G, Juvé R, Andreu A.

Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1549-56. doi: 10.1007/s10096-016-2696-7. Epub 2016 Jun 2.


Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.

Lee SG, Lee H, Jeong SH, Yong D, Chung GT, Lee YS, Chong Y, Lee K.

J Antimicrob Chemother. 2010 Apr;65(4):669-75. doi: 10.1093/jac/dkp505. Epub 2010 Jan 21.


High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P.

Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80. doi: 10.1128/AAC.05760-11. Epub 2011 Dec 12.


Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.

Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M; Antibiotic-Resistant Gonorrhea Study Group.

Antimicrob Agents Chemother. 2013 Nov;57(11):5225-32. doi: 10.1128/AAC.01295-13. Epub 2013 Aug 12.


Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.

Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, Malejczyk M, Domeika M, Unemo M.

BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65.


First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.

Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS.

J Antimicrob Chemother. 2016 Jan;71(1):92-9. doi: 10.1093/jac/dkv321. Epub 2015 Oct 15.


Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.

Thakur SD, Levett PN, Horsman GB, Dillon JA.

Sex Transm Infect. 2014 Jun;90(4):297-302. doi: 10.1136/sextrans-2013-051229. Epub 2014 Feb 6.


Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.

Liang JY, Cao WL, Li XD, Bi C, Yang RD, Liang YH, Li P, Ye XD, Chen XX, Zhang XB.

BMC Infect Dis. 2016 Apr 14;16:152. doi: 10.1186/s12879-016-1469-3.


Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?

Jeverica S, Golparian D, Matičič M, Potočnik M, Mlakar B, Unemo M.

J Antimicrob Chemother. 2014 Jun;69(6):1517-25. doi: 10.1093/jac/dku026. Epub 2014 Feb 16.


Supplemental Content

Support Center